{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:43:16Z","timestamp":1790239396455,"version":"4.1.0"},"reference-count":25,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2017.7359","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T08:52:31Z","timestamp":1510131151000},"source":"Crossref","is-referenced-by-count":6,"title":["Mitochondrial pathway\u2011mediated apoptosis is associated with erlotinib\u2011induced cytotoxicity in hepatic cells"],"prefix":"10.3892","author":[{"given":"Xueqin","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelong","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"key20200714082319_b1-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20200714082319_b2-ol-0-0-7359","article-title":"SEER cancer statistics review 1975\u20132012","author":"Howlader","year":"2015","journal-title":"Natl Cancer Inst"},{"key":"key20200714082319_b3-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.lungcan.2008.04.016","article-title":"Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer","volume":"63","author":"Iranzo","year":"2009","journal-title":"Lung Cancer"},{"key":"key20200714082319_b4-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3892\/etm.2012.714","article-title":"Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine","volume":"4","author":"Ozkaya","year":"2012","journal-title":"Exp Ther Med"},{"key":"key20200714082319_b5-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open-label, randomized, phase 3 study","volume":"12","author":"Zhou","year":"2011","journal-title":"Lancet oncol"},{"key":"key20200714082319_b6-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomized phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol"},{"key":"key20200714082319_b7-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.2174\/092986709788803097","article-title":"Current concepts of mechanisms in drug-induced hepatotoxicity","volume":"16","author":"Russmann","year":"2009","journal-title":"Curr Med Chem"},{"key":"key20200714082319_b8-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/emmm.201200235","article-title":"Inhibitors of mitochondrial Kv1. 3 channels induce Bax\/Bak-independent death of cancer cells","volume":"4","author":"Leanza","year":"2012","journal-title":"EMBO Mol Med"},{"key":"key20200714082319_b9-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/hep.23720","article-title":"Pharmacogenetics of drug-induced liver injury","volume":"52","author":"Russmann","year":"2010","journal-title":"Hepatology"},{"key":"key20200714082319_b10-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ctrv.2012.09.004","article-title":"Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis","volume":"39","author":"Teo","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"key20200714082319_b11-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10863-015-9620-1","article-title":"17-Demethoxy-reblastatin, an Hsp90 inhibitor, induces mitochondria-mediated apoptosis through downregulation of Mcl-1 in human hepatocellular carcinoma cells","volume":"47","author":"Zhao","year":"2015","journal-title":"J Bioenerg Biomembr"},{"key":"key20200714082319_b12-ol-0-0-7359","first-page":"2001","article-title":"Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: Implications for its hepatotoxicity","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"key20200714082319_b13-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2013.08.006","article-title":"Saikosaponin D disrupts platelet-derived growth factor-\u03b2 receptor\/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: A potential mechanism of hepatotoxicity","volume":"206","author":"Chen","year":"2013","journal-title":"Chem Biol Interact"},{"key":"key20200714082319_b14-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"33533","DOI":"10.1074\/jbc.273.50.33533","article-title":"Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant","volume":"273","author":"Oliver","year":"1998","journal-title":"J Biol Chem"},{"key":"key20200714082319_b15-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09857","article-title":"RIP3 mediates the embryonic lethality of caspase-8-deficient mice","volume":"471","author":"Kaiser","year":"2011","journal-title":"Nature"},{"key":"key20200714082319_b16-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1600-079X.2007.00488.x","article-title":"Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection","volume":"43","author":"Guha","year":"2007","journal-title":"J Pineal Res"},{"key":"key20200714082319_b17-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.etap.2015.11.005","article-title":"Activation of Fas death receptor pathway and Bid in hepatocytes is involved in saikosaponin D induction of hepatotoxicity","volume":"41","author":"Zhang","year":"2016","journal-title":"Environ Toxicol Pharmacol"},{"key":"key20200714082319_b18-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1055\/s-2008-1073114","article-title":"Etiologies of acute liver failure","volume":"28","author":"Lee","year":"2008","journal-title":"Semin Liver Dis"},{"key":"key20200714082319_b19-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1517\/17425255.2014.920823","article-title":"Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: From preclinical models to patients","volume":"10","author":"McGill","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key20200714082319_b20-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.fct.2013.04.031","article-title":"Fas receptor-deficient lpr mice are protected against acetaminophen hepatotoxicity due to higher glutathione synthesis and enhanced detoxification of oxidant stress","volume":"58","author":"Williams","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"key20200714082319_b21-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1172\/JCI59755","article-title":"The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation","volume":"122","author":"McGill","year":"2012","journal-title":"J Clin Invest"},{"key":"key20200714082319_b22-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/toxsci\/kfv319","article-title":"Low dose acetaminophen induces reversible mitochondrial dysfunction associated with transient c-Jun N-terminal kinase activation in mouse liver","volume":"150","author":"Hu","year":"2016","journal-title":"Toxicol Sci"},{"key":"key20200714082319_b23-ol-0-0-7359","first-page":"685","article-title":"Drug induced hepatotoxicity in targeted therapy for lung cancer","volume":"17","author":"Chen","year":"2014","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"key20200714082319_b24-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.taap.2012.04.010","article-title":"Oxidative stress is involved in Dasatinib-induced apoptosis in rat primary hepatocytes","volume":"261","author":"Xue","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20200714082319_b25-ol-0-0-7359","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.18632\/oncotarget.3357","article-title":"Autophagy protects against dasatinib-induced hepatotoxicity via p38 signaling","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T08:13:01Z","timestamp":1594714381000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.7359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3892\/ol.2017.7359","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,8]]}}}